No abstract

No abstract

Purpose: To evaluate the efficacy of drop trigonelline and oral trigonelline (TG) treatment in a model of N-methyl D-aspartate (NMDA)-induced retinal apoptosis in rat retina. To compare with brimonidine tartrate (BT) drops with known retinal neuroprotective activity.Methods: 42 Wistar Albino male rats were randomly divided into 6 groups of 7 each. No action was applied to Group 1. Group 2 (negative control) was given intravitreal Phosphate Bufferd Saline (PBS) on the first day of the experiment and did not receive any treatment. Groups 3, 4, 5 and 6 were given intravitreal NMDA on the first day of the experiment. Group 3 (positive control) didn't receive post-injection treatment. For 21 days from the second day of the experiment, oral TG was given to group 4, TG drops were given group 5 and BT drops were given group 6. Histopathological and biochemical evaluations were performed in all groups.Results: Severe retinal degeneration was observed in group 3 compared to group 2 (p<0.001).There was no statistically significant difference between group 1 and group 2 (p>0.05). TUNEL, Brn3a and caspase3 staining in group 5 and group 6 were similar to group 2 (p>0.05). Group 5 and group 6 compared to group 3 were observed significant decrease in iNOS levels(p<0.05). Decreasing MDA levels and increasing SOD levels were detected in group 4,5,6 compared to group 3 (p<0.05).Conclusion: In our study, it was determined that TG drops showed similar retinal neuroprotective efficacy to BT drops.